Back
Akero Therapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
61
AKRO
Akero Therapeutics
Last Price:
31.22
Seasonality Move:
5.92%
Buy
57
MDGL
Madrigal Pharmaceuticals
Last Price:
329.17
Seasonality Move:
43.27%
Buy
61
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $30.64. The Score for AKRO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $317.09. The Score for MDGL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $30.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $317.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight selling pressure.
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 49.43 | Sell |
Chaikin Money Flow: | -52673 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.33 - 33.05) | Sell |
Bollinger Bands (100): | (24.84 - 30.44) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 21.53 | Buy |
Relative Strength Index (14 RSI): | 61.98 | Buy |
Chaikin Money Flow: | -13589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (219.68 - 334.02) | Buy |
Bollinger Bands (100): | (218.08 - 294.46) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.68 | Sell |
20-day SMA: | 31.41 | Sell |
50-day SMA: | 29.63 | Buy |
200-day SMA: | 25.21 | Buy |
8-day EMA: | 30.77 | Sell |
20-day EMA: | 30.97 | Sell |
50-day EMA: | 29.78 | Buy |
200-day EMA: | 27.2 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 315.01 | Buy |
20-day SMA: | 293.81 | Buy |
50-day SMA: | 248.85 | Buy |
200-day SMA: | 247.65 | Buy |
8-day EMA: | 312.37 | Buy |
20-day EMA: | 295.42 | Buy |
50-day EMA: | 267.97 | Buy |
200-day EMA: | 245.53 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.10 per share, and an increase next year of $10.03 per share.
Akero Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |